Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy

Rizzardi, G. Paolo; Harari, Alexandre; Capiluppi, Brunella; Tambussi, Giuseppe; Ellefsen, Kim; Ciuffreda, Donatella; Champagne, Patrick; Bart, Pierre-Alexandre; Chave, Jean-Philippe; Lazzarin, Adriano; Pantaleo, Giuseppe
March 2002
Journal of Clinical Investigation;3/1/2002, Vol. 109 Issue 5, p681
Academic Journal
journal article
Primary HIV-1 infection causes extensive immune activation, during which CD4(+) T cell activation supports massive HIV-1 production. We tested the safety and the immune-modulating effects of combining cyclosporin A (CsA) treatment with highly active antiretroviral therapy (HAART) during primary HIV-1 infection. Nine adults with primary HIV-1 infection were treated with CsA along with HAART. At week 8, all patients discontinued CsA but maintained HAART. Viral replication was suppressed to a comparable extent in the CsA + HAART cohort and in 29 control patients whose primary infection was treated with HAART alone. CsA restored normal CD4(+) T cell levels, both in terms of percentage and absolute numbers. The increase in CD4(+) T cells was apparent within a week and persisted throughout the study period. CsA was not detrimental to virus-specific CD8(+) or CD4(+) T cell responses. At week 48, the proportion of IFN-gamma-secreting CD4(+) and CD4(+)CCR7(-) T cells was significantly higher in the CsA + HAART cohort than in the HAART-alone cohort. In conclusion, rapid shutdown of T cell activation in the early phases of primary HIV-1 infection can have long-term beneficial effects and establish a more favorable immunologic set-point. Appropriate, immune-based therapeutic interventions may represent a valuable complement to HAART for treating HIV infection.


Related Articles

  • Temporal trends in presentation for outpatient HIV medical care 2000-2010: implications for short-term mortality. Seal, Paula; Jackson, David; Chamot, Eric; Willig, James; Nevin, Christa; Allison, Jeroan; Raper, James; Kempf, Mirjam; Schumacher, Joseph; Saag, Michael; Mugavero, Michael; Seal, Paula S; Jackson, David A; Willig, James H; Nevin, Christa R; Allison, Jeroan J; Raper, James L; Kempf, Mirjam C; Schumacher, Joseph E; Saag, Michael S // JGIM: Journal of General Internal Medicine;Jul2011, Vol. 26 Issue 7, p745 

    Background: Many newly diagnosed patients present to outpatient care with advanced HIV infection. More timely HIV diagnosis and initiation of care has the potential to improve individual health outcomes and has public health implications.Objective: To assess temporal...

  • Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure. Skurnick, Joan H.; Palumbo, Paul; DeVico, Anthony; Shacklett, Barbara L.; Valentine, Fred T.; Merges, Michael; Kamin-Lewis, Roberta; Mestecky, Jiri; Denny, Thomas; Lewis, George K.; Lloyd, Joan; Praschunus, Robert; Baker, Amanda; Nixon, Douglas F.; Stranford, Sharon; Gallo, Robert; Vermund, Sten H.; Louria, Donald B. // Journal of Infectious Diseases;2/15/2002, Vol. 185 Issue 4, p428 

    Seventeen women who were persistently uninfected by human immunodeficiency virus type 1 (HIV-1), despite repeated sexual exposure, and 12 of their HIV-positive male partners were studied for antiviral correlates of non-transmission. Thirteen women had > or = 1 immune response in the form of CD8...

  • HIV treatment outcomes among people who inject drugs in Victoria, Australia. Walsh, Nick; Mijch, Anne; Watson, Kerrie; Wand, Handan; Fairley, Kit; McNeil, John; Crofts, Nick; Maher, Lisa // BMC Infectious Diseases;2014, Vol. 14 Issue 1, p919 

    Background People who inject drugs (PWID) are a key population affected by HIV. We assessed the effectiveness of HIV treatment among a clinical cohort of people living with HIV (PLHIV) diagnosed and referred for community-based antiretroviral therapy (ART) in Victoria, Australia. Methods HIV...

  • Effectiveness of ritonavir-boosted protease inhibitor monotherapy in the clinical setting: same results as in clinical trials? The PIMOCS Study Group. Curran, Adrian; Monteiro, Polyana; Domingo, Pere; Villar, Judit; Imaz, Arkaitz; Martínez, Esteban; Fernández, Irene; Knobel, Hernando; Podzamczer, Daniel; Iribarren, Jose Antonio; Peñaranda, María; Crespo, Manuel // Journal of Antimicrobial Chemotherapy (JAC);May2014, Vol. 69 Issue 5, p1390 

    Objectives Ritonavir-boosted protease inhibitor monotherapy (PIMT) is a maintenance strategy that prevents nucleoside reverse transcriptase inhibitor toxicity and reduces costs. Some trials compare PIMT with combined antiretroviral therapy, but restricted selection criteria and low sample size...

  • Growth hormone enhances thymic function in HIV-1-infected adults. Napolitano, Laura A.; Schmidt, Diane; Gotway, Michael B.; Ameli, Niloufar; Filbert, Erin L.; Ng, Myra M.; Clor, Julie L.; Epling, Lorrie; Sinclair, Elizabeth; Baum, Paul D.; Kai Li; Killian, Marisela Lua; Bacchetti, Peter; McCune, Joseph M.; Li, Kai // Journal of Clinical Investigation;Mar2008, Vol. 118 Issue 3, p1085 

    Growth hormone (GH) is an underappreciated but important regulator of T cell development that can reverse age-related declines in thymopoiesis in rodents. Here, we report findings of a prospective randomized study examining the effects of GH on the immune system of HIV-1-infected adults. GH...

  • Effect of Nadir CD4+ T Cell Count on Clinical Measures of Periodontal Disease in HIV+ Adults before and during Immune Reconstitution on HAART. Vernon, Lance T.; Demko, Catherine A.; Babineau, Denise C.; Wang, Xuelei; Toossi, Zahra; Weinberg, Aaron; Rodriguez, Benigno // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Background:The contribution of HIV-infection to periodontal disease (PD) is poorly understood. We proposed that immunological markers would be associated with improved clinical measures of PD. Methods:We performed a longitudinal cohort study of HIV-infected adults who had started highly...

  • MACH14: A Multi-Site Collaboration on ART Adherence Among 14 Institutions. Liu, Honghu; Wilson, Ira; Goggin, Kathy; Reynolds, Nancy; Simoni, Jane; Golin, Carol; Rosen, Marc; Gross, Robert; Wagner, Glenn; Remien, Robert; Schneiderman, Neil; Erlen, Judith; Arnsten, Julia; Bangsberg, David // AIDS & Behavior;Jan2013, Vol. 17 Issue 1, p127 

    The integration of original data from multiple antiretroviral (ARV) adherence studies offers a promising, but little used method to generate evidence to advance the field. This paper provides an overview of the design and implementation of MACH14, a collaborative, multi-site study in which a...

  • Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. Turner, Barbara J.; Fleishman, John A.; Wenger, Neil; London, Andrew S.; Burnam, M. Audrey; Shapiro, Martin F.; Bing, Eric G.; Stein, Michael D.; Longshore, Douglas; Bozzette, Samuel A.; Turner, B J; Fleishman, J A; Wenger, N; London, A S; Burnam, M A; Shapiro, M F; Bing, E G; Stein, M D; Longshore, D; Bozzette, S A // JGIM: Journal of General Internal Medicine;Sep2001, Vol. 16 Issue 9, p625 

    Objective: To distinguish the effects of drug abuse, mental disorders, and problem drinking on antiretroviral therapy (ART) and highly active ART (HAART) use.Design: Prospective population-based probability sample of 2,267 (representing 213,308) HIV-infected persons in...

  • Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily. CELESIA, B. M.; CASTRONUOVO, D.; PINZONE, M. R.; BELLISSIMO, F.; MUGHINI, M. T.; LUPO, G.; SCARPINO, M. R.; GUSSIO, M.; PALERMO, F.; COSENTINO, S.; CACOPARDO, B.; NUNNARI, G. // European Review for Medical & Pharmacological Sciences;Aug2013, Vol. 17 Issue 16, p2218 

    OBJECTIVES: Across Europe, more than one third of patients are diagnosed with HIV infection late. Late presentation for care has been associated with higher risk of clinical progression and mortality. In the present study, we evaluated the prevalence, epidemiological characteristics and survival...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics